[Assessment of the myorelaxant Sirdalud (produced by Sandoz company) on pain intensity in acute radicular syndromes].
Piłkowska
E
E
I Kliniki Neurologicznej Instytutu Psychiatrii i Neurologii, Warszawie.
Wieczorkiewicz
M
M
Kulczycki
J
J
D000328:Adult; D003161:Compartment Syndromes / Q000188:drug therapy* / Q000503:physiopathology; D005116:Extrapyramidal Tracts / Q000187:drug effects / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology
D009125:Muscle Relaxants, Central
Ocena środka miorelaksujacego Sirdalud firmy Sandoz na nasilenie bólów w ostrych zespołach korzeniowych.